Insulin-like growth factors and their role in osteoporosis

Calcified Tissue International

Volumn 58, Issue 3, 1996, Pages 133-134

  Canalis, Ernesto ^a   Agnusdei, Donato ^b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN C;

BONE REMODELING; EDITORIAL; HUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

BONE REMODELING; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; OSTEOPOROSIS;

EID: 0030092937     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02526877     Document Type: Article

References (14)

1. Canalis E, Pash J, Varghese S (1993) Skeletal growth factors. Crit Rev Eukaryot Gene Express 3:155-166
2. Delany AM, Pash J, Canalis E (1994) Cellular and clinical perspectives on skeletal insulin-like growth factor I. J Cell Biochem 55:328-333
3. Hammerman MR (1987) Insulin-like growth factors and aging. Endocinol Metab Clin North Am 16:995-1008
4. Romagnoli E, Minisola S, Carnevale V, Rosso R, Pacitti MT, Scarda A, Scamecchia L, Mazzuoli G (1994) Circulating levels of insulin-iike growth factor binding protein 3 (IGFBP-3) and insulin-like growth factor I (IGF-I) in perimenopausal women. Osteoporos Int 4:305-308
5. Romagnoli E, Minisola S, Carnevale V, Scarda A, Rosso R, Scarnecchia L, Pacitti MT, Mazzuoli G (1993) Effect of estrogen deficiency on IGF-I plasma levels: relationship with bone mineral density in perimenopausal women. Calcif Tissue Int 53:1-6
6. Nicolas V, Prewett A, Bettica P, Mohan S, Finkelman RD, Baylink DJ, Farley JR (1994) Age-related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab 78:1011-1016
7. Delany AM, Dong Y, Canalis E (1994) Mechanisms of glucocorticoid action in bone cells. J Cell Biochem 56:295-302
8. Canalis E (1992) Clinical review 35: growth factors and their potential clinical value. J Clin Endocrinol Metab 75:1-4
9. Canalis E (1995) Growth hormone, skeletal growth factors and osteoporosis. Endocr Pract 1:39-43
10. Clemmons DR (1992) Editorial: role of insulin-like growth factor-I in reversing catabolism. J Clin Endocrinol Metab 75:1183-1196
11. Ebeling PR, Jones ID, O'Fallon WM, Janes CH, Riggs BL (1993) Short-term effects of recombinant human insulin-like growth factor-I on bone turnover in normal women. J Clin Endocrinol Metab 77:1384-1387
12. Grinspoon SK, Baum HBA, Peterson S, Kilbanski A (1995) Effects of rhIGF-I administration on bone turnover during short-term fasting. J Clin Invest 96:900-906
13. Canalis E, Centrella M, Burch M, McCarthy TL (1989) Insulin-like growth factor I mediates selected anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60-65
14. Finkelstein JS, Klibanski A, Schaefer EH, Hornstein MD, Schiff I, Neer RM (1994) Parathyroid hormone for the prevention of bone loss induced by cstrogen deficiency. N Engl J Med 331:1618-1623